A randomised, double-blind, placebo-controlled, dose ascending, 4 period crossover study to examine the safety, tolerability, pharmacodynamics and pharmacokinetics of repeat inhaled doses of GW597901X in asthmatic subjects.
Phase of Trial: Phase I
Latest Information Update: 20 May 2009
At a glance
- Drugs GSK 597901 (Primary)
- Indications Asthma
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 20 May 2009 Trial phase changed from phase II to phase I as reported by ClinicalTrials.gov.
- 28 Sep 2006 New trial record.